Global MicroRNA Market to Reach US$ 666.7 Mn by 2025 –

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
59
Global MicroRNA Market to Reach US$ 666.7 Mn by 2025 – Persistence Market Research

New York, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Global microRNA market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by increasing demand of microRNA re-agents and kits for various applications that could eventually translate into developing innovative therapeutic solutions for various difficult-to-treat illnesses. According to the new report published by Persistence Market Research titled, “MicroRNA Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),” which tracks the performance of global microRNA market for the period of eight years, i.e. 2017-2025, the global market is projected to register a CAGR of 7.9% in terms of value during the forecast period. The market is anticipated to be valued at US$ 666.7 Mn by 2025.

Global MicroRNA Market: Restraints

  • Poor reproducibility of research and specificity of products
  • Complication in vendor selection due to large product portfolios
  • Requirement of skilled personnel and limited availability of data analysis tools
  • In-house development of assays for microrna detection
  • RNA is more challenging to handle
  • High cost associated with microrna reagents and other similar products
  • Limited life science research infrastructure in emerging markets

Global Market Research Report Overview on MicroRNA @ https://www.persistencemarketresearch.com/mar...market.asp

Global MicroRNA Market: Forecast by Assay Type

On the basis of assay type, the global microRNA market is segmented into PCR-based Assay, miRNA Arrays, Next Generation Sequencing (NGS), and Immunoassay. Immunoassay segment is further segmented into Fluorescent Assays, Colorimetric Assays, and Chemiluminescent Assays. On the basis of assay type, PCR based arrays segment accounted for 34.9% market share in 2016 in terms of revenue, which is expected to increase to 36.9% by 2025 end. Next generation sequencing is expected to be the second largest segment in terms of revenue growth in microRNA market and is expected to register a CAGR of 8.1% over the forecast period.

Global MicroRNA Market: Forecast by Application

On the basis of application, the global microRNA market is segmented into Clinical Diagnostics and Research. Research is the largest segment in global microRNA market, which is estimated to represent US$ 275.7 Mn, or 76.1% share of the total market in 2017 and US$ 525.6 Mn, or 78.8% by 2025 end, expanding at CAGR of 8.4% over the forecast period. Research segment dominated the global microRNA market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Research segment is expected to be the most lucrative among all end users, with attractiveness index of 1.6.

A Sample of this report is available upon request@ https://www.persistencemarketresearch.com/samples/3464

Global MicroRNA Market: Forecast by End User

On the basis of end-user, the global microRNA market is segmented into Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, and Diagnostic Centers. Academic & research institutes end user is the largest segment in global microRNA market, which is estimated to represent US$ 138.9 Mn of the total market in 2017 and is anticipate to be valued at US$ 255.9 Mn by 2025 end, expanding at CAGR of 7.9% over the forecast period. Academic & research institutes dominated the global microRNA market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period.

Global MicroRNA Market: Forecast by Region

Five regions have covered in this report such as North America, Latin America, Europe, APAC and MEA. North America is the largest region in microRNA market, which is estimated to represent US$ 140.3 Mn, or 38.7% share of the total market in 2017 and is projected to reach to US$ 245.9 Mn, or 36.9%, expanding at CAGR of 7.3% over the forecast period of 2017–2025. Europe is expected to be the second most lucrative market, with attractiveness index of 1.3 during the forecast period.

View Report Table of Contents, Figures, and Tables@ https://www.persistencemarketresearch.com/mar...market/toc

Global MicroRNA Market: Key Players

Some of the key players operating in the global microRNA market are Illumina, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Bio-Rad Laboratories Inc.,Sigma Aldrich Corp., Qiagen N.V, Thermo Fisher Scientific, Inc., HTG Molecular Diagnostics, Inc., Bioline GmbH (A Meridian Life Science Company), Rosetta Genomics Ltd., Dharmacon, a Horizon Discovery Group Co., BioVendor — Laboratorní medicína a.s., Miltenyi Biotec, Kaneka Corporation (Eurogentec), Abcam Plc, GeneCopoeia, Inc., Promega Corporation, New England Biolabs, Inc., NanoString Technologies, Inc., and System Biosciences LLC.

Global MicroRNA Market Report is Available for US$ 4,900

Persistence Market Research Overview

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Persistence Market Research U.S. Sales Office: 305 Broadway, 7th Floor New York City, NY 10007 +1-646-568-7751 United States USA - Canada Toll-Free: 800-961-0353 Email: sales@persistencemarketresearch.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Real-Time Video Solutions with Haivision on AWS

Updated Category News Views 90

Haivision StreamHub and MoJoPro Revolutionize Mobile Broadcasting Haivision Systems Inc. (TSX: HAI), a leader in real-time video networking, has launched an innovative mobile broadcasting solution. Now available on the AWS Marketplace, the pairing of Haivision StreamHub with the MoJoPro app changes the game for journalists, video professionals, and broadcasters. They can...

Continue Reading
Keurig Dr Pepper's Strategic Acquisition Plans for JDE Peet's

Updated Category News Views 298

Keurig Dr Pepper's Strategic Acquisition Plans for JDE Peet's In a noteworthy announcement, Keurig Dr Pepper Inc. (NASDAQ: KDP) and JDE Peet's N.V. are making headlines with their plans regarding a public offer. This joint statement serves to inform stakeholders about the progress on KDP's intended recommended public offer for all outstanding shares of JDE Peet's. Basis...

Continue Reading
Join Wreaths Across America: Make a Difference This Season

Updated Category News Views 93

Join Wreaths Across America This December This December, Wreaths Across America (WAA), a national nonprofit, is gearing up for a meaningful wreath season. With over 20 new loads in need of carrier support, WAA is on the lookout for dedicated carriers and professional drivers who want to take part in its mission to Remember, Honor, and Teach. This initiative is set to...

Continue Reading
iMD Companies to Introduce New Product Line for Supplements

Updated Category News Views 159

iMD Companies and Riize Health Launch New Supplements iMD Companies, Inc. (OTC: ICBU) and its subsidiary, Riize LLC, are making waves in the health sector by introducing three new non-prescription products designed for online and retail distribution. The launch is set for the first quarter of the upcoming year and aims to cater directly to consumer needs in the...

Continue Reading
Activist Investors Surge: A Look into 2025's Landscape

Updated Category News Views 1737

Activist Investors Surge in 2024 By Svea Herbst-Bayliss A remarkable shift occurred in 2024 as a record number of activist shareholders launched campaigns aimed at global companies. Recent reports highlight that tactics employed by these shareholders have yielded impressive returns, which suggests a continued rise in these activities as we progress into the future. Rising...

Continue Reading